These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19928582)

  • 21. Modulation of the cytochrome P450 system as a mechanism of chemoprotection.
    Wolf CR; Mahmood A; Henderson CJ; McLeod R; Manson MM; Neal GE; Hayes JD
    IARC Sci Publ; 1996; (139):165-73. PubMed ID: 8923029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
    Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes.
    Linnet K; Olesen OV
    Drug Metab Dispos; 1997 Dec; 25(12):1379-82. PubMed ID: 9394027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4.
    Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T
    Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 enzymes and genotype-guided drug therapy.
    Roederer MW
    Curr Opin Mol Ther; 2009 Dec; 11(6):632-40. PubMed ID: 20072940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.
    Strolin Benedetti M; Whomsley R; Baltes E
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):895-921. PubMed ID: 17125408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens.
    Djordjević D; Nikolić J; Stefanović V
    Pathol Biol (Paris); 1998 Dec; 46(10):760-70. PubMed ID: 9922992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P450 structures and oxidative metabolism of xenobiotics.
    Lewis DF
    Pharmacogenomics; 2003 Jul; 4(4):387-95. PubMed ID: 12831319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer.
    Nedelcheva V; Gut I
    Xenobiotica; 1994 Dec; 24(12):1151-75. PubMed ID: 7771104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 systems--biological variations of electron transport chains.
    Hannemann F; Bichet A; Ewen KM; Bernhardt R
    Biochim Biophys Acta; 2007 Mar; 1770(3):330-44. PubMed ID: 16978787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Drugs on oxygen": an update and perspective on the role of cytochrome P450 testing in pharmacology.
    Tralau T; Luch A
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1357-62. PubMed ID: 22970688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Importance of the metabolic oxidation of drugs and other xenobiotics: recent developments].
    Fleury MB
    Ann Pharm Fr; 2011 Jan; 69(1):1-2. PubMed ID: 21296211
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
    Niwa T; Murayama N; Yamazaki H
    Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-based amperometric platform to determine the polymorphic response in drug metabolism by cytochromes P450.
    Panicco P; Dodhia VR; Fantuzzi A; Gilardi G
    Anal Chem; 2011 Mar; 83(6):2179-86. PubMed ID: 21348440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 57 varieties: the human cytochromes P450.
    Lewis DF
    Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans.
    Breimer DD; Schellens JH
    Trends Pharmacol Sci; 1990 Jun; 11(6):223-5. PubMed ID: 2200179
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics.
    Brosen K
    Clin Pharmacokinet; 1990 Mar; 18(3):220-39. PubMed ID: 2182263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.